Category: Joint ventures/collaborations
-
Trial Shows Electronic Dressing Stops Biofilm Infections in Burns
Findings from a clinical trial show a dressing for burns with an electric current prevents formation of bacterial films, reducing risks of infections.
-
Gene Therapy Shown to Build Knee Cartilage
Findings from research with lab animals shows a single gene therapy injection delivered with a benign virus helps build new knee cartilage cells and tissue.
-
Trial Testing VR to Relieve Cancer Patient Distress
A clinical trial is underway assessing virtual reality interventions for relieving distress and improve the quality of life for cancer patients receiving bone marrow transplants.
-
Start-Up Licensing Antibody Eye Drops for Dry Eye Disease
An enterprise spun off from university labs is licensing its technology to a drug maker for eye drops with immune-system antibodies to treat dry eye disease.
-
Business-Academic Team to Create RNA Delivery for Cancer
A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles.
-
mRNA Aerosol Delivered to Lungs to Treat Pneumonia
Messenger RNA, inhaled from an aerosol spray, is shown in lab rats with pneumonia to reduce inflammation, improve lung functions, and protect against further infections.
-
Company-Academic Team to Test Vocal Indicators of Cognitive Decline
Researchers from a digital health company and academic medical center are beginning a pilot study of indicators in human voices for remote detection of mild cognitive decline.
-
NIH Award Funds A.I. to Detect Alzheimer’s in Clinical Notes
A small-business grant to a developer of natural language analytics for health care aims to detect evidence of cognitive decline from physicians’ notes in electronic health records.
-
Collaboration Developing Microbiome Boost to Cancer Immunotherapy
A biotechnology company creating treatments that work with gut microbes is partnering with M.D. Anderson Cancer Center on more effective cancer immunotherapies.
-
New Venture Funds to Back Life Science, Tech Start-Ups
Three new venture funds are seeking to invest up to $6.3 billion in start-up companies with advances in life sciences, health care, energy, and information technologies.